financetom
Market
financetom
/
Market
/
CLSA estimates impact of Rs 9,000 crore for banks for fourth quarter
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CLSA estimates impact of Rs 9,000 crore for banks for fourth quarter
Apr 9, 2021 10:06 AM

The Reserve Bank of India (RBI) has maintained the status quo on rates in the monetary policy. Brokerage firm CLSA states that the RBI's decision to maintain the status quo highlights two important developments and data points.

First, while the fortnight data is not out yet, overall credit growth has moderated to 5.6 percent year-on-year (March 26) from 6.5 percent (March 12). This implies a 1.6 percent year-on-year (YoY) sequential growth in the last fortnight versus 2.5-3.0 percent sequential growth in the past few years, implying that credit growth trends remain muted mainly due to weak corporate loan growth and will be a key monitorable aspect for the sustained rerating of large private banks.

The brokerage firm’s base case is 8-9 percent YoY credit growth over FY2022/23 primarily driven by the normalisation of retail growth to over15 percent.

Second, the RBI has asked banks to give an account of interest on interest waivers and refunds for all borrowers in the fourth quarter of FY21. Also, the government had funded interest on interest reversal for loans less than Rs 2 crore. For loans over Rs 2 crore, banks will have to account for the impact in the fourth quarter of FY2021 and will need to see if the government will foot that bill later.

CLSA estimates an impact of Rs 9,000 crore for banks for the fourth quarter of FY2021 and this will be a one-time hit of less than 10 basis points of loans based on the forecast.

(Edited by : Jomy)

First Published:Apr 9, 2021 7:06 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Equities Mixed Intraday as Traders Parse Corporate Earnings, Macro Data
Equities Mixed Intraday as Traders Parse Corporate Earnings, Macro Data
Nov 3, 2024
02:31 PM EDT, 10/25/2024 (MT Newswires) -- US benchmark equity indexes were mixed intraday as markets weighed the latest corporate earnings and economic data. The Dow Jones Industrial Average was down 0.6% at 42,127.1 after midday Friday, while the Nasdaq Composite rose 0.5% to 18,515.3. The S&P 500 was little changed at 5,803.1. Among sectors, financials and utilities saw the...
Top Midday Gainers
Top Midday Gainers
Nov 3, 2024
02:31 PM EDT, 10/25/2024 (MT Newswires) -- ImmunityBio ( IBRX ) shares soared 66% in recent trading Friday after the company reported Thursday dosing of the first patients in a phase 1 trial that will assess its CAR-NK cellular therapy as a potential treatment for non-Hodgkin's lymphoma. Over 43 million shares traded intraday versus a daily average of roughly 2.9...
Sector Update: Tech
Sector Update: Tech
Nov 3, 2024
03:25 PM EDT, 10/25/2024 (MT Newswires) -- Tech stocks gained late Friday afternoon, with the Technology Select Sector SPDR Fund (XLK) rising 0.6% and the SPDR S&P Semiconductor ETF (XSD) climbing 1.5%. The Philadelphia Semiconductor index advanced 1.3%. In corporate news, Evolv Technologies ( EVLV ) shares plunged 38% after the company said it is delaying its Q3 earnings report...
Sector Update: Health Care
Sector Update: Health Care
Nov 3, 2024
03:29 PM EDT, 10/25/2024 (MT Newswires) -- Health care stocks were lower late Friday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each shedding 0.5%. The iShares Biotechnology ETF (IBB) rose 0.2%. In corporate news, Upexi ( UPXI ) shares soared 242% after the company said it was investigating an instance of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved